Global research states and trends of micro RNA in irritable bowel syndrome: a bibliometric analysis.

Irritable bowel syndrome (IBS) affects millions of people worldwide, causing chronic digestive problems like abdominal pain, bloating, and altered bowel habits. Despite its prevalence, doctors still struggle to diagnose and treat IBS effectively. Researchers recently analyzed 124 scientific studies to understand how tiny molecules called microRNAs might help us better understand and manage this condition.

This comprehensive review examined global research patterns and found that scientists are increasingly interested in how microRNAs—small genetic molecules that control how our cells function—play important roles in IBS. The research shows these molecules are involved in several key problems seen in IBS patients: increased gut sensitivity to pain, disrupted intestinal barriers that protect us from harmful substances, inflammation in the digestive tract, and miscommunication in the brain-gut connection. The studies also revealed that imbalances in gut bacteria (microbiome disruption) may interact with microRNAs to contribute to IBS symptoms.

What does this mean for people considering acupuncture? While this study didn't directly investigate acupuncture, understanding these biological mechanisms is important because acupuncture has been shown in other research to influence inflammation, gut motility, and the brain-gut axis—the same systems affected by microRNAs in IBS. As scientists identify specific molecular targets in IBS, integrative approaches like acupuncture may work alongside conventional treatments to address multiple aspects of this complex condition. If you're considering acupuncture for IBS symptoms, consult with a licensed acupuncturist experienced in digestive disorders.

This bibliometric analysis examined 124 publications from the Web of Science Core Collection investigating non-coding RNAs (ncRNAs), particularly microRNAs (miRNAs), in irritable bowel syndrome pathophysiology. Using VOSviewer, Citespace, and Excel for analysis, researchers identified key research trends from predominantly Chinese, American, and German institutions. The review revealed that miRNAs regulate critical IBS pathologies including visceral hypersensitivity, intestinal permeability, mucosal barrier dysfunction, immunoinflammatory responses, and brain-gut axis dysregulation. Notably, ncRNAs appear to mediate interactions between intestinal microbiota and host systems. Clinical relevance: While this study focuses on molecular mechanisms rather than interventions, understanding miRNA involvement in inflammation, barrier function, and neuroenteric signaling provides biological context for acupuncture's documented effects on these same pathways in IBS management. No specific effect sizes reported; this is a descriptive bibliometric review of research trends rather than a clinical trial.